欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/4453/001
药品名称	OMsan 0,020 mg/0,100 mg überzogene Tabletten
活性成分	ethinyl estradiol 0.02 mg levonorgestrel 0.1 mg
剂型	Coated tablet
上市许可持有人	Aenova IP GmbH Temmlerstr. 2 D-35039 Marburg Germany
参考成员国 - 产品名称	Germany (DE) MILEVA 20
互认成员国 - 产品名称
许可日期	2016/10/10
最近更新日期	2022/11/16
药物ATC编码	G03AA07 levonorgestrel and ethinylestradiol
申请类型	TypeLevel1：Abridged TypeLevel2：Initial Application TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final SPC \| common_final_spc_4453_001__V010Date of last change:2023/03/16 Final PL \| common_final_pl_4453_001__V010Date of last change:2022/11/16 Final Product Information \| common-final-labip-4453(002)-V001GDate of last change:2018/02/28 Final Product Information \| common-final-labip-4453(001)-V001GDate of last change:2018/02/28 Final Product Information \| common-final-pl-4453(001)-V001GDate of last change:2018/02/28 Final Product Information \| common-final-labop-4453(001)-V001GDate of last change:2018/02/28 Final Product Information \| common-final-labop-4453(002)-V001GDate of last change:2018/02/28 Final Product Information \| common-final-spc-4453(001)-V001GDate of last change:2018/02/28 Final Product Information \| common-final-pl-4453(002)-V001GDate of last change:2018/02/28 Final Product Information \| common-final-spc-4453(002)-V001GDate of last change:2018/02/28 PAR \| DE-4453_01-02_Mileva_Mithra_final_PARDate of last change:2018/02/26
市场状态	Positive